AstraZeneca PLC (AZN)
92.51
-0.01
(-0.01%)
USD |
NASDAQ |
Dec 30, 16:00
92.27
-0.24
(-0.26%)
Pre-Market: 09:07
AstraZeneca Market Cap: 286.83B for Dec. 30, 2025
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| GSK Plc | 99.07B |
| Amgen, Inc. | 176.99B |
| Gilead Sciences, Inc. | 152.83B |
| Regeneron Pharmaceuticals, Inc. | 81.34B |
| Bicycle Therapeutics Plc | 471.70M |
Market Cap Related Metrics
| PE Ratio | 30.72 |
| PS Ratio | 4.973 |
| PEG Ratio | 0.6871 |
| Price to Book Value | 6.251 |
| Price to Free Cash Flow | 29.26 |
| Price | 92.51 |
| Earnings Yield | 3.26% |
| PEGY Ratio | 0.662 |
| Operating PE Ratio | 22.73 |
| Normalized PE Ratio | 30.10 |